Uncategorized

The investors accused Sernova’s board of “complacently” overseeing “a period of eroding shareholder value.”

U.S. District Judge John Koeltl rejected UnitedHealth’s argument that New York’s surprise billing law prevents providers from taking legal action against payers for alleged underpayments.

Results from two late-stage trials showed the Merck-Eisai combo treatment failed to boost survival in two difficult-to-treat advanced cancers.

John Glaser, an executive in residence at Harvard Medical School, and Ranil Herath, president at Emeritus Healthcare, address healthcare’s digital transformation and how to successfully adapt to change.

Akebia Therapeutics, Inc. today announced that it will present posters at the National Kidney Foundation (NKF) Spring Clinical Meetings 2023 (SCM23), which will take place on demand and live in Austin, Texas.

PhenomeX Inc. (Nasdaq: CELL), the functional cell biology company, today announced its participation at the American Association of Cancer Research (AACR) Annual Meeting 2023 being held from April 14-19 at the Orange County Convention Center in Orlando, Fla.

M2GEN , an oncology-focused health informatics solutions company, today announced its participation as a presenter, exhibitor, and research partner at the American Association for Cancer Research (AACR) Annual Meeting April 14-19, 2023.

At the World Vaccine Congress, antimicrobial resistance as a global health crisis grabbed top billing.

Seres Therapeutics, Inc. (Nasdaq: MCRB) (“Seres” or the “Company”), a leading microbiome therapeutics company, today announced that on April 5, 2023, the Compensation and Talent Committee of Seres’ board of directors granted inducement equity grants covering an aggregate of 22,000 shares of its common stock to three new employees, consisting of stock options to purchase

Select Medical Holdings Corporation (“Select Medical”) (NYSE: SEM), will release the financial results for its first quarter ended March 31, 2023 on Thursday, May 4, 2023 after the market closes.